Cite
HARVARD Citation
Barratt, J. et al. (n.d.). MO533: Safety of Roxadustat versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies. Nephrology dialysis transplantation. p. . [Online].